Orthofix Medical Inc. Future Amortization Expense, Year Three (Deprecated 2012-01-31)
Orthofix Medical Inc. (OFIX) reported Future Amortization Expense, Year Three (Deprecated 2012-01-31) of $1.30 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-07-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FutureAmortizationExpenseYearThree · last filed 2012-07-30
- Orthofix Medical Inc. future amortization expense, year three (deprecated 2012-01-31) for the quarter ending 2012-06-30 was $100.00K.
- Orthofix Medical Inc. future amortization expense, year three (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $1.20M.
- Orthofix Medical Inc. future amortization expense, year three (deprecated 2012-01-31) for fiscal 2011 was $1.50M.
| Period end | Future Amortization Expense, Year Three (Deprecated 2012-01-31) 3 month | Future Amortization Expense, Year Three (Deprecated 2012-01-31) 6 month | Future Amortization Expense, Year Three (Deprecated 2012-01-31) 12 month |
|---|---|---|---|
| 2012-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-30 | $1.30M 10-Q · filed 2012-07-30 | |
| 2012-03-31 | $1.20M 10-Q · filed 2012-05-04 | ||
| 2011-12-31 | $1.50M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |